BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu X, Deng X, Lu C, Chen Y, Jie L, Zhang Q, Li W, Wang Z, Du Y, Yu R. SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent. Quant Imaging Med Surg 2018;8:770-80. [PMID: 30306057 DOI: 10.21037/qims.2018.09.03] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Van NH, Vy NT, Van Toi V, Dao AH, Lee B. Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration. OpenNano 2022. [DOI: 10.1016/j.onano.2022.100064] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Mazumder A, Dwivedi A, Assawapanumat W, Saeeng R, Sungkarat W, Nasongkla N. In vitro galactose-targeted study of RSPP050-loaded micelles against liver hepatocellular carcinoma. Pharm Dev Technol 2022;:1-13. [PMID: 35388736 DOI: 10.1080/10837450.2022.2063891] [Reference Citation Analysis]
3 Editorial Office. Erratum to SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent. Quant Imaging Med Surg 2022;12:1660-2. [PMID: 35111659 DOI: 10.21037/qims-2021-05] [Reference Citation Analysis]
4 Madamsetty VS, Mukherjee A, Paul M. Bioinspired nanoparticles-based drug delivery systems for cancer theranostics. Biogenic Nanoparticles for Cancer Theranostics 2021. [DOI: 10.1016/b978-0-12-821467-1.00008-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ferreira MI, Cova T, Paixão JA, Pais A, Vitorino C. Coprecipitation synthesis, stabilization, and characterization of oleic acid-coated iron oxide nanoparticles for magnetically oriented hybrid system vectorization. Magnetic Nanoparticle-Based Hybrid Materials 2021. [DOI: 10.1016/b978-0-12-823688-8.00033-8] [Reference Citation Analysis]
6 Ong YS, Bañobre-López M, Costa Lima SA, Reis S. A multifunctional nanomedicine platform for co-delivery of methotrexate and mild hyperthermia towards breast cancer therapy. Mater Sci Eng C Mater Biol Appl 2020;116:111255. [PMID: 32806240 DOI: 10.1016/j.msec.2020.111255] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
7 Mohseni M, Connell JJ, Payne C, Patrick PS, Baker R, Yu Y, Siow B, Zaw-thin M, Kalber TL, Pankhurst QA, Lythgoe MF. Scalable magnet geometries enhance tumour targeting of magnetic nano-carriers. Materials & Design 2020;191:108610. [DOI: 10.1016/j.matdes.2020.108610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Karami S, Rostamizadeh K, Shademani N, Parsa M. Synthesis and Investigation of the Curcumin-Loaded Magnetic Lipid Nanoparticles and Their Cytotoxicity Assessment on Human Breast Carcinoma Cell Line. Jundishapur J Nat Pharm Prod 2020;15. [DOI: 10.5812/jjnpp.91886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Beringhs AO, Sadabad RK, Lu X. Advances and clinical challenges in biomaterials for in vivo tumor imaging. Biomaterials for Cancer Therapeutics. Elsevier; 2020. pp. 291-329. [DOI: 10.1016/b978-0-08-102983-1.00011-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Gauthier L, Varache M, Couffin AC, Lebrun C, Delangle P, Gateau C, Texier I. Quantification of Surface GalNAc Ligands Decorating Nanostructured Lipid Carriers by UPLC-ELSD. Int J Mol Sci 2019;20:E5669. [PMID: 31726778 DOI: 10.3390/ijms20225669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]